পদ্ধতির তুলনা করুন
নির্বাচিত পদ্ধতিগুলো পাশাপাশি পর্যালোচনা করুন; যে সারিগুলোয় পার্থক্য আছে সেগুলো চিহ্নিত করা হয়।
| SCORAD Index (SCORing Atopic Dermatitis)× | Skindex-29 (স্কিন ডিজিজ কোয়ালিটি অফ লাইফ ইনস্ট্রুমেন্ট)× | |
|---|---|---|
| ক্ষেত্র | ত্বকবিজ্ঞান | ত্বকবিজ্ঞান |
| পরিবার | Process / pipeline | Process / pipeline |
| উদ্ভবের বছর≠ | 1993 | 1997 |
| প্রবর্তক≠ | European Task Force on Atopic Dermatitis (ETFAD) | Chren MM, Lasek RJ |
| ধরন≠ | Clinician-rated | Self-report |
| মৌলিক উৎস≠ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ | Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1997;107(5):707-713. DOI ↗ |
| অপর নাম≠ | SCORAD Index | Skindex, Skindex-QoL |
| সম্পর্কিত≠ | 3 | 1 |
| সারসংক্ষেপ≠ | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. | Skindex-29 is a validated, patient-centered quality-of-life measure specifically designed to assess the impact of any skin disease on patients' symptoms, emotions, and functioning. Developed by Chren, Lasek, and colleagues in 1997, it captures the multidimensional burden of dermatological conditions beyond clinical severity. Skindex-29 is widely used in clinical trials, observational studies, and dermatology practice to ensure that treatment efficacy encompasses quality-of-life outcomes. |
| ScholarGateডেটাসেট ↗ |
|
|